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ABSTRACT
Background: Collation of aphasia research data across settings, coun-
tries and study designs using big data principles will support analyses 
across different language modalities, levels of impairment, and therapy 
interventions in this heterogeneous population. Big data approaches in 
aphasia research may support vital analyses, which are unachievable 
within individual trial datasets. However, we lack insight into the 
requirements for a systematically created database, the feasibility and 
challenges and potential utility of the type of data collated.
Aim: To report the development, preparation and establishment of 
an internationally agreed aphasia after stroke research database of 
individual participant data (IPD) to facilitate planned aphasia 
research analyses.
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Methods: Data were collated by systematically identifying existing, 
eligible studies in any language (≥10 IPD, data on time since stroke, 
and language performance) and included sourcing from relevant 
aphasia research networks. We invited electronic contributions and 
also extracted IPD from the public domain. Data were assessed for 
completeness, validity of value-ranges within variables, and 
described according to pre-defined categories of demographic 
data, therapy descriptions, and language domain measurements. 
We cleaned, clarified, imputed and standardised relevant data in 
collaboration with the original study investigators. We presented 
participant, language, stroke, and therapy data characteristics of 
the final database using summary statistics.
Results: From 5256 screened records, 698 datasets were potentially 
eligible for inclusion; 174 datasets (5928 IPD) from 28 countries 
were included, 47/174 RCT datasets (1778 IPD) and 91/174 (2834 
IPD) included a speech and language therapy (SLT) intervention. 
Participants’ median age was 63 years (interquartile range [53, 72]), 
3407 (61.4%) were male and median recruitment time was 321 days 
(IQR 30, 1156) after stroke. IPD were available for aphasia severity or 
ability overall (n = 2699; 80 datasets), naming (n = 2886; 75 data-
sets), auditory comprehension (n = 2750; 71 datasets), functional 
communication (n = 1591; 29 datasets), reading (n = 770; 12 data-
sets) and writing (n = 724; 13 datasets). Information on SLT inter-
ventions were described by theoretical approach, therapy target, 
mode of delivery, setting and provider. Therapy regimen was 
described according to intensity (1882 IPD; 60 datasets), frequency 
(2057 IPD; 66 datasets), duration (1960 IPD; 64 datasets) and dosage 
(1978 IPD; 62 datasets).
Discussion: Our international IPD archive demonstrates the appli-
cation of big data principles in the context of aphasia research; our 
rigorous methodology for data acquisition and cleaning can serve 
as a template for the establishment of similar databases in other 
research areas.
Background
Big data approaches to data synthesis and analysis typically involve collation of large 
datasets to reveal patterns, trends, and associations which would be overlooked in single 
trials due to a lack of statistical power. These approaches generate data “high in volume 
and diversity, gathered from single participants to large groups, at one or more time 
points” (Auffray et al., 2016), and can be applied to a range of health care settings. Big data 
methods have several advantages, the most important being sample size (Fan et al., 
2014). Synthesising large volumes of data, facilitates greater representation of the popu-
lation under investigation, whilst also reducing research waste (Rumsfeld et al., 2016). 
Collating data at the level of the individual, instead of at the level of aggregated, group or 
summary data, permits analyses that can account for individual confounders and missing 
data, and mitigates ecological bias, which can arise when using aggregated or group level 
data.
Historically, primary aphasia research studies in the stroke population have enrolled 
and analysed smaller sample sizes due to the heterogeneity of the population (Plowman 
et al., 2012), recruitment challenges (Wallace, 2010), the assessment of a variety of 
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outcomes (Flowers et al., 2016), with data gathered on a range of stroke, aphasia and 
language measurement tools, capturing information on selected language modalities and 
conducting assessments in a range of different languages. Additionally, there is hetero-
geneity in the availability of participant, intervention and outcome data across existing 
aphasia research (Brady et al., 2020), limiting clinical implementation of research findings. 
The feasibility of developing a large aphasia individual participant data (IPD) database is 
challenging due to the differences in study designs (e.g., randomised controlled trials 
‘RCTs’, case studies, cohorts), data collection time points, approaches for collecting, 
processing and interpreting data (Brady et al., 2016). Generating high-quality data, 
which is representative of people affected by post-stroke aphasia, representing the 
different language domains (e.g., everyday communication, auditory comprehension, 
naming, reading comprehension and writing), time since stroke, overall aphasia severity 
and therapy data (e.g., approaches, frequency, intensity, duration, and dosage) in large 
numbers would facilitate important language recovery analyses, both within and 
between sub-populations. Pooling pre-existing IPD from international studies in a large, 
multi-disciplinary, multi-lingual database offers a cost and time-effective (Nishimura et al., 
2016) approach to addressing current aphasia research priorities (Franklin et al., 2018; 
Pollock et al., 2012).
The specialised nature of aphasia research provides opportunities to work colla-
boratively with internationally renowned research hubs to collate datasets across 
languages, research settings, and using different measurement tools. However, this 
can also pose a challenge to synthesising and standardizing IPD into a uniform 
format for analyses, and relies on working closely with collaborators, ensuring trust 
in how data are to be collated, stored, used, analysed and acknowledged in 
subsequent publications. Each of these aspects of international collaborative work 
is essential in order to build an IPD resource which can be adopted internationally. 
Yet the feasibility of the development and aggregation of such diverse research 
and clinical datasets into a big-data archive is currently unknown within the field of 
aphasia rehabilitation.
We report here on the outcome of an international, multidisciplinary collaborative 
effort to systematically develop the REhabilitation and recovery of peopLE with Aphasia 
after StrokE (RELEASE) IPD database, highlighting the feasibility of developing a big data 
post-stroke aphasia research resource and providing a template for replication by 
researchers in other areas of neuro-rehabilitation and communication research.
Methods
Full details on the search strategy, study selection, collation, data management, data 
extraction and synthesis are described in our published protocol (Brady et al., 2020)
Ethical approval and study registration
We received university ethical approval to collate data in the RELEASE archive (HLS/NCH/15/ 
09). Principal investigators of included studies obtained local ethical approval for sharing 
their data to the RELEASE database as required. Our protocol was registered with the 
international prospective register of systematic reviews (PROSPERO CRD42018110947), 
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and the database was approved by the UK’s Integrated Research Application System (IRAS; 
179,505).
Dataset identification & management
We conducted a systematic search of existing literature to identify potential datasets in 
any language that met our eligibility criteria; IPD for a minimum of ten participants with 
stroke-related aphasia, time since stroke information and a measurement of language 
ability (Brady et al., 2020). Working copies of original datasets were given a unique 
identifier, standardised to SAS Inc. 9.4 software for data management, and stored with 
all available associated dataset documents (e.g., study protocols, papers and data dic-
tionaries). Extracted data items were recorded in a data extraction table in accordance 
with the Template for Intervention Description and Replication (TIDieR) guidelines in 
reporting complex interventions (Hoffmann et al., 2014). We standardised the format, 
coding and units of measurement of variables, maximising the number of available IPD 
for analysis and documented this on a decision log. At primary dataset level, we 
described study design, inclusion/exclusion criteria, recruitment date (or publication 
date as a proxy when recruitment date was unavailable), sample size, country and 
language, data collection time point(s), blinding of assessors, dropouts and for RCTs, 
randomisation method and allocation concealment. Participant level data included demo-
graphic, stroke and language impairment information. Data cleaning and categorisation 
decisions were taken in collaboration with the wider RELEASE group. Where possible, 
each dataset profile summary was sent to the collaborating investigator for review and 
approval prior to inclusion in the final RELEASE database.
Risk of bias assessment in individual studies
We assessed methodological quality according to selection, detection, attrition and other 
potential sources of bias as previously detailed (Brady et al., 2020). We coded studies with 
potential risk of bias as low, unclear, or high risk, and appraised the impact of these 
potential biases.
Risk of bias across studies
We maintained an inclusive approach to dataset acceptance. Our systematic review used 
a broad search strategy and intentionally inclusive pre-defined eligibility criteria. Data 
extraction errors were minimised by two researchers independently reviewing data, and 
through verification of electronic contributions with primary researchers.
Outcomes
In collaboration with the contributing researchers, we categorised language measure-
ments into the following language domains: overall language ability, spoken language 
production (including a sub-category for naming), auditory comprehension, reading 
comprehension, writing and functional communication. Data for each outcome measure-
ment instrument were investigated for validity, for example, by examining ranges, outliers 
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and missing-ness of data with queries resolved (where possible) through communication 
with collaborators.
Summary statistics
We described the contents of the database using summary statistics. Continuous variables 
were described using medians and interquartile ranges (IQR), while categorical variables 
were described using frequencies and percentages. Where possible, we described the 
measurement tools that were used to capture each of the language domains of interest, 
the number of studies that used the measurement, the IPD available and missing, and 
instances where the measurement tool was used but the data was not reported.
Results
Datasets
Following the systematic search, 11,314 records were identified. After the removal of 
duplicates, we screened 5256 records, excluding 2935 ineligible records. We excluded 
a further 1210 following abstract review and an additional 433 records after a review of 
the full texts (Figure 1). We invited the authors of 698 potentially eligible reports to 
contribute the associated IPD. Of which, 592 did not result in data contribution as 193/592 
were trial registration records, no responses were received from 318/592 research teams, 
IPD from 78 datasets were unavailable IPD, and 3/592 declined to participate. We received 
125 expressions of interest relating to eligible datasets and identified a further 99 eligible 
datasets in the public domain (Figure 1). Our RELEASE database thus comprised of 174 
datasets with 5928 IPD from 28 countries, in 23 languages; 13 were unpublished. We 
received 75/174 (43.1%) datasets electronically (3940/5928, 66.5% IPD), and included 99 
(56.9%) from the public domain (1988, 33.5% IPD).
Study types
More than a quarter of the primary research studies 47/174 (27.0%) were RCTs (1778/5928, 
30.0% IPD); over half 104/174 (59.8%) were a case series or cohort design (2886, 48.7% 
IPD); non-randomized controlled trial studies whereby participants were recruited to 
groups, but random allocation was not applied (non RCTs) accounted for 18/174 
(10.3%) datasets (n = 411, 6.9% IPD). The remaining 2.9% (5/174) of datasets came from 
registries (853, 1.4% IPD). Data inclusion in each planned analysis was on a dataset-by- 
dataset basis and did not necessarily reflect the primary research study designs. For 
example, in some cases, participants were randomly allocated to two (non-SLT) interven-
tions but all received the same SLT treatment. In such cases, the IPD were variously 
analysed as a single cohort or by group depending on the nature of the dataset and 
the planned analyses. Availability of data on randomised allocation also impacted the 
analysis; for example one primary research report described an RCT study design but IPD 
on group allocation was unavailable as the researchers reported the dataset as a single 
cohort.
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Participants
Participants had a median age of 63 (IQR 53–72) years, most 3407/5550 IPD (61.4%) were 
male (Table 1) and median formal education was 12 years (IQR 10–16). Median participant 
recruitment time was 321 days (IQR 30–1156) after stroke (5841/5928 IPD, 98.5%). Three 












No data contributed n = 592
Trial registration only n = 193; No response n = 318;
IPD irretrievable n = 78; Declined n = 3
Full texts excluded n = 433
Non-aphasia/stroke/language n = 272; Insufficient sample size n
= 77; No primary data n = 52; Full text unavailable n = 28;
Qualitative data only n = 4
Titles excluded n = 2935
Non-aphasia/stroke/language n = 2321; No primary data n = 
225; Insufficient sample size n = 183; Incompleted records n =
109; Duplicates n = 87; Qualitative data only n = 10
Abstracts excluded n = 1210
Insufficient sample size n = 495; Non-aphasia/stroke/language
n = 380;No primary data n = 242; Study ongoing n = 55;
Qualitative data only n = 30; Trial registration n = 8
Expression of interest
n = 125
Datasets unavailable n = 267
Electronic datasets





























n = 99; IPD = 1988
Included
174 Datasets; 5928 IPD
Volunteered datasets
n = 20
Figure 1. PRISMA flow diagram: Eligible database identification and contribution.
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of total 5928 Sub-Category Available IPD (%)
Sex 158 (90.8) 5,550 (93.6) Male 3,407 (61.4)
Female 2,143 (38.6)
Handedness 111 (63.8) 3,879 (65.4) Right 3,719 (95.9)
Left 133 (3.4)
Ambidextrous 27 (0.7)






Living Context 21 (12.1) 701 (11.8) Living with others 473 (67.5)
Living alone 146 (20.8)
Formal care environment 70 (10.0)
Mixed 12 (1.7)
Stroke 97 (55.7) 3,416 (57.6) Ischaemic 2,795 (81.8)
Intracerebral Haemorrhage 547 (16.0)
Subarachnoid Haemorrhage 31 (0.9)
Mixed 42 (1.2)
Aneurysm 1 (0.03)
Prior Stroke 45 (25.8) 1,274 (21.5) No 1164 (91.4)
Yes 110 (8.6)
Affected Hemisphere 130 (74.7) 4,130 (69.7) Left 3,965 (96.0)
Right 81 (2.0)
Bilateral 84 (2.0)
Socioeconomic Status 4 (2.3) 175 (3.0) - 175 (0.03)
Visual Impairment 35 (20.1) 1,494 (25.2) No impairment 1,122 (75.1)
Impairment present 60 (4.0)
Corrected 312 (20.9)
Cognitive Impairment 100 (57.5) 3,945 (66.5) No impairment 3,347 (84.8)
Impairment present 7 (0.2)
Score reported 591 (15.0)
Dysarthria 19 (10.9) 937 (15.8) No dysarthria 634 (67.7)
Dysarthria 111 (11.8)
Mild 155 (16.5)
No or Mild 23 (2.5)
No severe 14 (1.5)
Apraxia 34 (19.5) 1,011 (17.1) No Apraxia 606 (59.9)
Apraxia 329 (32.5)
Very mild apraxia 1 (0.1)
No severe apraxia 36 (3.6)
Mild-Moderate apraxia 7 (0.7)
Moderate-Severe apraxia 2 (0.2)
Assessment score available 30 (3.0)
Depression 62 (35.6) 2075 (35.0) Absent 1,723 (83.0)
Present 352 (17.0)
Median [IQR]
Days since stroke 173 (99.4) 5841 (98.5) - 321; [30–1,156]
Age (years) 169 (97.1) 5,785 (97.6) - 63; [53–72]
Education (years) 84 (48.3) 3125 (52.7) - 12; [10–16]
Stroke Severity 8 (4.6) 716 (12.1) NIHSS 11; [5–17]
6 (3.4) 489 (8.2) mRS 4; [3–4]
5 (2.9) 442 (7.5) BI (0–20 scale) 16; [9–20]
BI (0–100 scale) 60; [15–95]
Key – IPD Individual Participant Data; % percentage; IQR Interquartile range; NIHSS National Institute of Health Stroke 
Scale; mRS Modified Rankin Scale; BI Barthel Index.
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others (473/701 IPD, 67.5%, Table 1). Ischaemic stroke (2795/3416 IPD, 81.8%) predomi-
nated stroke aetiology and stroke typically affected the left hemisphere (3965/4130, 
96.0%). The majority of participants were right-handed (3719/3879, 95.9%) with no visual 
impairment (1122/1494; 75.1% IPD); 111 participants (11.8%) were classified as also 
having dysarthria, and 329 (32.5%) were recorded as having aphasia along with apraxia 
of speech (Table 1).
Data were collected across 28 countries, in 23 languages, the majority in English (3162/ 
5928, 53.3% IPD). Of the 79 datasets reporting date of recruitment, participants were 
recruited between 1973 and 2018. Of 161 published datasets, 26 (16.1% datasets; 664/ 
4627 IPD, 14%) were published before 2000.
Outcomes
A total of 64 language measurement tools, which captured the outcomes relevant to our 
database across 174 datasets were included (Table 2). The measurement tool used by the 
Table 3. Overall language ability assessment tools (at baseline) included in RELEASE – Datasets and 
IPD where measure is reported, available, missing from report, or unavailable.




Assessed but  
unavailable (IPD)
Aachen Aphasia Test (AAT) overall Severity Score 1 (12,0) 15 (537)
Afazi Dil Değerlendirme Testi (ADD) 1 (30,23) 0 (0)
Aphasia Handicap Scale (AHS) 2 (39,19) 0 (0)
Aphasia Severity Rating Scale (ASRS) 14 (441,6) 0 (0)
Boston Assessment of Severe Aphasia (BASA) 1 (15,0) 0 (0)
Comprehensive Aphasia Test (CAT) 3 (433,37) 5 (180)
Norsk Grunntest for Afaxi (NGA) 3 (62,0) 0 (0)
Porch Index of Communicative Ability (PICA) 8 (171,1) 0 (0)
Short Norsk Grunntest for Afasi (Short NGA) 2 (241,0) 0 (0)
Sprachsystemtisches Aphasie Screening (SAPS) 1 (133,9) 0 (0)
Standard Language Test of Aphasia (SLTA) 2 (24,0) 1 (36)
Western Aphasia Battery - Aphasia Quotient* 35 (733,0) 0 (0)
Western Aphasia Battery-Revised Aphasia Quotient 6 (69,0) 1 (18)
Western Aphasia Battery-Cantonese 1 (105,0) 0 (0)
Western Aphasia Battery-Japanese 1 (24,0) 0 (0)
Western Aphasia Battery- Korean 3 (125,3) 0 (0)
Western Aphasia Battery-Persian 2 (86,0) 0 (0)
Key *Anchor Measure; IPD Individual Participant Data.
Table 2. Data availability for language outcomes.
Language outcome
Datasets 
N = 174 (%)
IPD 
n = 5928 (%)
Overall language ability 80 (46.0) 2699 (45.5)
Naming 75 (43) 2886 (48.7)
Other spoken language 9 (5.2) 380 (6.4)
Auditory comprehension 71 (40.8) 2750 (46.4)
Reading comprehension 12 (6.9) 770 (13.0)
Writing 13 (7.5) 724 (12.2)
Function communication – observer rated 29 (16.7) 1591 (26.8)
Functional communication – self rated 3 (1.7) 68 (1.1)
Key-IPD Individual Participant Data; % percentage; N = total datasets; n = total IPD
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Table 4a. Naming assessments (at baseline) included in RELEASE – Datasets and IPD where measure is 






Assessed but unavailable 
(IPD)
Aachen Aphasia Test (AAT) 16 (524,14) 1 (11)
Afazi Dil Degerlendirme Testi (ADD) 1 (53,0) 0 (0)
Batteria per l’Analisi dei Deficit Afasici (BADA) 2 (12,0) 1 (6)
BETA 1 (127,134) 0 (0)
Boston Diagnostic Aphasia Examination (BDAE) 7 (0, 0) 7 (115)
Boston Naming Test (BNT)/60* 30 (831,0) 0 (0)
Boston Naming Test (BNT)/30 2 (21,0) 0 (0)
Boston Naming Test (BNT) Short From 3 (129,0) 0 (0)
Boston Diagnostic Aphasia Examination Greek version (G- 
BDAE)
2 (38,0) 1 (12)
Boston Diagnostic Aphasia Examination Polish version (P- 
BDAE)
1 (40,0) 0 (0)
Cambridge Naming Test (CNT) 1 (70,0) 0 (0)
Comprehensive Aphasia Test (CAT) 4 (479,5) 4 (129)
Graded Naming Test 1 (11,0) 0 (0)
Greek Boston Naming Test 1 (38,0) 0 (0)
Korean Boston Naming Test 1 (10,0) 0 (0)
Lisbon Aphasia Assessment Battery (LAAB) 2 (55,0) 0 (0)
Norsk Grunntest for Afaxi (Full NGA) 1 (39,0) 2 (23)
Object Naming Test 3 (53,0) 0 (0)
PALPA 53 1 (11,0) 0 (0)
Philadelphia Naming Test (PNT) 2 (25,0) 0 (0)
Porch Index of Communicative Ability (PICA) 3 (52,0) 5 (120)
Psychological Assessment of Language (PAL) 2 (81,3) 0 (0)
Snodgrass and Vanderwort 3 (80,0) 0 (0)
Standard Language Test of Aphasia (SLTA) 2 (36,0) 1 (24)
VNT 1 (260,54) 0 (0)
Western Aphasia Battery 2 (44,0) 20 (381)
Western Aphasia Battery-Revised 6 (72,0) 1 (15)
Western Aphasia Battery-Cantonese 1 (105,0) 0 (0)
Western Aphasia Battery- Korean 3 (117,1) 1 (10)
Western Aphasia Battery- Mandarin 1 (23,0) 0 (0)
Key: IPD Individual participant data; *Anchor Measure
Table 4b. Other spoken language assessments (at baseline) included in RELEASE – Datasets and IPD 
where measure is reported, available, missing from report or unavailable.




Assessed but  
unavailable (IPD)
Boston Diagnostic Aphasia Examination Greek version  
(G-BDAE)
2 (38,0) 1 (12)
Communication Disability Profile (CDP) 1 (25,0) 0 (0)
Porch Index of Communicative Ability (PICA)* 2 (40,0) 6 (132)
Schuell 1 (10,0) 0 (0)
Standard Language Test of Aphasia (SLTA) 2 (24,0) 1 (36)
Sprachsystemtisches Aphasie Screening (SAPS) 1 (139,3) 0 (0)
Western Aphasia Battery-Cantonese 1 (105,0) 0 (0)
Western Aphasia Battery- Korean 1 (21,0) 2 (107)
Key: IPD Individual participant data; *Anchor Measure
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most datasets for each language outcome became an “anchor measure” to which the 
scores of all other tools measuring the same domain were transformed (see Table 3–7 for 
anchor and minority measures of overall language and each language domain). Many 
datasets (80/174;46.0%) included a measure of overall language ability (2699/5928, 45.5% 
IPD), 75 (43.0%) used a naming measure (2886, 48.7% IPD), and 71 (40.8%) measured 
auditory comprehension (2750, 46.4% IPD). Other language domains of interest (func-
tional communication, writing, reading comprehension and other spoken language) were 
also measured but by smaller numbers of primary research teams (Table 2). Available 
measurement tools were profiled by language modality (Table 3–7). For some datasets 
measurement tools described in accompanying study documentation, were unavailable 
in a format that could be profiled or analysed for each language domain and were 
unavailable from the primary research team. For example, the Aachen Aphasia Test 
(AAT), while described in reports relating to 17 datasets, only 16/17 had AAT IPD available 
for one or more of the language outcomes relevant to our database.
Table 5. Auditory comprehension assessments (at baseline) included in RELEASE – Datasets and IPD 







Aachen Aphasia Test (AAT) 3 (194,2) 13 (353)
AAT Italian Version of Token Test -T score 1 (11,0) 0 (0)
AAT Token Test* 15 (505,0) 0 (0)
AAT Token Test T Score 2 (27,0) 0 (0)
Afazi Dil Değerlendirme Testi (ADD) 1 (53,0) 0 (0)
Batteria per l’Analisi dei Deficit Afasici (BADA) 1 (12,0) 1 (6)
Boston Aphasia Severity Assessment (BASA) 9 (15,0) 0 (0)
Boston Diagnostic Aphasia Examination (BDAE) 7 (115,0) 0 (0)
BDAE 3 1 (29,0) 0 (0)
BDAE 12 1 (11,0) 0 (0)
Greek version of BDAE (G-BDAE) 2 (50,0) 0 (0)
Communication Disability Profile (CDP) 9 (6,0) 1 (19)
Comprehensive Aphasia Test (CAT) 6 (576,6) 2 (31)
DeRenzi, Vignolo Token Test/62 2 (34,0) 0 (0)
DeRenzi, Vignolo Token Test/36 10 (639,0) 0 (0)
DeRenzi Modified Short form of the Token Test 3 (53,0) 0 (0)
Lisbon Aphasia Assessment Battery (LAAB) 2 (55,0) 0 (0)
Montreal Toulouse 1 (11,0) 0 (0)
Norsk Grunntest for Afaxi (NGA) 3 (62,0) 0 (0)
Peabody Picture Vocabulary Test (PPVT) 2 (33,3) 0 (0)
Pizzamigglion Sentence Comprehension Test (PSCT) 1 (25,11) 0 (0)
Porch Index of Communicative Ability (PICA) 3 (52,0) 5 (120)
Psychological Assessment of Language (PAL) 2 (79,5) 0 (0)
Revised Token Test Arvedson, McNeil & West/five item 1 (16,0) 0 (0)
Schuell 1 (10,0) 0 (0)
Sprachsystematisches Aphasiescreening (SAPS) 1 (136,6) 0 (0)
Standard Language Test of Aphasia (SLTA) 2 (60,0) 0 (0)
Token Test/15 1 (25,0) 0 (0)
Western Aphasia Battery 3 (54,0) 19 (371)
Western Aphasia Battery-Revised 5 (71,1) 1 (15)
Western Aphasia Battery-Cantonese 1 (105,0) 0 (0)
Western Aphasia Battery- Korean 2 (117,1) 1 (10)
Key-IPD Individual Participant Data; *Anchor Measure.
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Interventions
Just over half the datasets described an SLT intervention (91/174 52.3%; 2746/5928, 
46.3% IPD). Data on language measurements were available at pre- and post- 
intervention time points for 67/174 (38.5%) datasets, comprising 2330/5928 IPD 
(39.3%). These 67 intervention studies were profiled by method of delivery, theore-
tical approach, and language treatment targets (Table 8). In 7/174 (4%) datasets, 
participants were allocated across three groups (different SLT interventions, in some 
cases with a control comparison group), (128/5928, 0.02% IPD), and in three datasets 
(1.7%) across four groups (84 IPD). Five datasets (4%) employed a delayed treatment 
start for one group (128/5928, 0.02% IPD). Therapy regime was described according 
to intensity (hours per week, 1882 IPD; 60 datasets), frequency (number of sessions 
Table 6a. Reading comprehension and writing assessments (at baseline) included in RELEASE – 





Assessed but  
unavailable (IPD)
Aachen Aphasia Test (AAT) 2 (54,2) 14 (493)
BETA 1 (126,135) 0 (0)
Boston Diagnostic Aphasia Examination (BDAE) 1 (13,0) 6 (102)
Boston Diagnostic Aphasia Examination Greek version (G-BDAE) 1 (38,0) 1 (12)
Comprehensive Aphasia Test (CAT)* 3 (460,7) 5 (146)
Norsk Grunntest for Afasi (NGA) 1 (39,0) 2 (23)
PALPA 31 1 (11,0) 0 (0)
PALPA 48 1 (11,0) 0 (0)
Schuell 1 (10,0) 0 (0)
Standard Language Test of Aphasia (SLTA) 1 (36,0) 1 (24)
Western Aphasia Battery 1 (13,0) 21 (412)
Western Aphasia Battery- Korean 1 (81,16) 2 (31)
Western Aphasia Battery- Mandarin 1 (23,0) 0 (0)
Key: IPD Individual Participant Data; *Anchor Measure.
Table 6b. Reading comprehension and writing assessments (at baseline) included in RELEASE – 





Assessed but  
unavailable (IPD)
Boston Diagnostic Aphasia Examination (BDAE) 1 (13,0) 6 (102)
Boston Diagnostic Aphasia Examination Greek version (G-BDAE) 1 (38,0) 1 (12)
Communication Disability Profile (CDP) 1 (24,0) 0 (0)
Comprehensive Aphasia Test (CAT)* 3 (454,13) 5 (146)
Norsk Grunntest for Afasi (NGA) 1 (39,0) 2 (23)
Porch Index of Communicative Ability (PICA) 3 (51,1) 5 (120)
Schuell 1 (10,0) 0 (0)
Standard Language Test of Aphasia (SLTA) 1 (24,0) 1 (36)
Western Aphasia Battery- Korean 1 (71,26) 2 (31)
Key: IPD Individual Participant Data; *Anchor Measure.
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per week, 2057 IPD; 66 datasets), duration (total number of days, 1960 IPD; 64 
datasets) and dosage (total hours, 1978 IPD; 62 datasets). Furthermore, interventions 
were delivered by professionals in 62 datasets (92.5%) and non-professionals in seven 
datasets (10.4%); in clinics, hospitals or rehabilitation settings in 48 datasets (71.6%) 
and at home in 17 datasets (23.4%).
Risk of meta-bias – across studies
From the 47 RCTs identified in a previous systematic review (Brady et al., 2016), we 
included IPD from 17 eligible trials, in addition to IPD from five trials that were on- 
going, and a further four trials that were unavailable at the time of that review. As 
a consequence of our systematic searching, we included 122 more datasets in our IPD 
database than we had identified a priori, increasing our original estimate from 3181 IPD to 
5928. This reduced the risk of selection bias and increased the availability of IPD. Due to 
the nature of our dataset, generation of funnel plots to assess publication bias were not 
Table 7a. Functional Communication (observer-rated) included in RELEASE – Datasets and IPD where 
measure is reported, available, missing from report or unavailable.
Functional Communication Assessment
Datasets
Reported (IPD  
available, missing)
Assessed but  
unavailable (IPD)
Aachen Aphasia Test (AAT) Spontaneous Speech* 8 (402,4) 8 (147)
American Speech and Hearing Association Functional assessment of  
communication skills
3 (135,0) 0 (0)
Amsterdam Nijmegen Everyday Language Test (ANELT) 7 (453,142) 0 (0)
Communication Activity Log (CAL) 1 (10,0) 0 (0)
Communication Effectiveness Index (CETI) 7 (300,0) 0 (0)
Communicative Pragmatic Screening (KOPS) 1 (131,11) 0 (0)
Functional Communication Profile 4 (249,5) 0 (0)
Mini Communication Activity Log (Mini CAL) 1 (24,0) 0 (0)
Scenario Test (2010) 1 (11,0) 0 (0)
Therapy Outcome Measures (TOMS) Activity 3 (257,1) 0 (0)
Therapy Outcome Measures (TOMS) Participation 3 (257,1) 0 (0)
Key: IPD Individual Participant Data; *Anchor Measure.
Table 7b. Functional Communication (self-rated) included in RELEASE – Datasets and IPD where 





Assessed but  
unavailable (IPD)
Assessment for Living with Aphasia (ALA)* 2 (43,2) 0 (0)
Communication Confidence Rating Scale for Aphasia (CCRSA) 1 (32,2) 0 (0)
Communication Disability Profile (CDP) Activity 1 (25,0) 0 (0)
Communication Disability Profile (CDP) Auditory Comprehension 1 (6,19) 0 (0)
Communication Disability Profile (CDP) Spoken Language 1 (25,0) 0 (0)
Communication Disability Profile (CDP) Participation 1 (25,0) 0 (0)
Communication Disability Profile (CDP) Writing 1 (24,1) 0 (0)
Key: IPD Individual Participant Data; *Anchor Measure.
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possible. Instead, we checked distribution between sample size and studies reporting 
significant results. Of the 164 published datasets, no evidence of publication bias by 
sample size was evident (chi-squared, p = 0.77 Table 9).
Risk of bias – within studies
Across the included RCTs there was a low risk of bias (random sequence generation, 
allocation concealment, blinding of outcome measure and a small number with unex-
plained attrition) (Figure 2). Of the total 47 RCTs included , 27 reported adequate genera-
tion of a random sequence; 22 described an adequate method to ensure concealment of 
allocation. Within RCTs, baseline differences between participants in the treatment 
groups were assessed for age (3/47 showing baseline differences), time since stroke (2/ 
Table 8. Speech and language therapy (SLT) Interventions in the RELEASE dataset.
Speech and language therapy intervention descriptor
Datasets 
N = 67 (%)
IPD 
n = 2330 (%)
SLT method of delivery Face-to-face 60 (89.6) 1957 (84.0)
Computer 15 (22.4) 315 (13.5)
Telephone 1 (1.5) 15 (0.6)
Constraint induced aphasia therapy 7 (10.4) 113 (4.8)
Self-managed 4 (6.0) 106 (4.5)
One-to-one 47 (70.1) 1613 (69.2)
Group 8 (11.9) 148 (6.4)
Mixed 9 (13.4) 207 (8.9)
Theoretical approach Semantic 2 (1.5) 34 (1.5)
Phonological 9 (13.4) 124 (5.3)
Semantic and phonological 15 (22.4) 260 (11.2)
Functional and pragmatic 8 (11.9) 246 (10.6)
Constraint induced aphasia therapy 7 (10.4) 113 (4.8)
Melodic intonation therapy 4 (6.0) 61 (2.6)
Conversational partner training 2 55 (2.4)
Target of Impairment Spoken language 41 734 (31.5)
Auditory comprehension 4 68 (2.9)
Auditory comprehension & spoken language 24 651 (27.9)
Reading 1 10 (0.4)
Writing 0 0
Note: Categories were not mutually exclusive; an intervention may span categories or appear more than once.
Table 9. Significant and non-significant results reported, by participant number.
Sample size (group) Significant result reported
Participants No
Yes 
% of total publications
>100 3 5 (63%)
>50 to 100 3 8 (73%)
>30 to 50 3 15 (83%)
>20 to 30 8 25 (76%)
>10 to 20 12 57 (83%)
Up to 10 5 20 (80%)
Key % percentage; > greater than.
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47 showing baseline differences) and language impairment (1/47 showing baseline 
differences) using the Wilcoxon signed rank test (Brady et al., in press). Between group 
baseline differences in sex were assessed using the chi-square test (1/47 showing baseline 
differences).
Blinding of outcome assessment was reported in 49/174 datasets (28.2%) though in 
many cases blinding was not relevant to the primary dataset study design (e.g., a clinical 
registry or observational study). An additional nine datasets (5.2%) described blinding for 
a subset of data and 117 datasets either did not report blinding (91/117) or had indicated 
that blinding was not present (25/117).
A third of the IPD were available in the public domain; some of these IPD datasets were 
only partially reported in those publications (for example, baseline data only) while in 
other cases full RCT datasets were available . Some primary research dataset electronic 
contributions were only partially available with published reports relating to that dataset 
indicatinghat additional data items were available at the time of publication.
Discussion
Using an international multidisciplinary collaborative approach, robust methodology, and 
applying big data principles within the context of aphasia research, we systematically 
created an international IPD database that adhered to data sharing guidelines (Knoppers, 
2014), and which ensured the feasibility of our analysis plan (Brady et al., 2020). Working 
with our collaborators and accessing data in the public domain, allowed us to include 
demographic, stroke, aphasia, language impairment and SLT intervention IPD from 28 
countries and language outcomes gathered using 64 measurement tools. Over half the 
datasets included an SLT intervention, IPD that can be used to inform future analyses to 
optimise the delivery of SLT in people with aphasia. Our database is representative of 
available aphasia research datasets and reflects the heterogeneity in data collection 
practices across a range of different study designs and contexts. Collation of these data 
highlighted variation in the measurement tools that were used to capture data within the 
same language domain and strengthens the evidence to support greater consistency in the 
use of an aphasia core outcome set (Wallace et al., 2019) in future aphasia research. 
Similarly, the need for greater consistency in the collection of participant descriptors in 
future aphasia studies was evident (The RELEASE Collaboration, 2020), and an international 
Figure 2. Randomised controlled trials included in the RELEASE database and risk of bias.
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consensus initiative to address this need is currently ongoing within the Collaboration of 
Aphasia Trialists (www.aphasiatrials.org/describe).
A key strength in our study was our international, collaborative approach, which 
involved multidisciplinary aphasia researchers and permitted the sharing of expertise and 
greater clarity on international aphasia research practice. Primary researchers were actively 
involved in the development and cleaning of data, thereby contributing to the validity, 
accuracy and robustness of the data contained within the archive.
The research landscape across a range of health settings has highlighted the impor-
tance of minimising research waste (Chan et al., 2014; Doubal et al., 2017), resulting in 
encouragement and recognition of the value (Taichman et al., 2016), in sharing research 
datasets to facilitate new analyses. Guidelines exist to support IPD sharing (Waithira et al., 
2019), with appropriate approvals, accreditation and acknowledgement (Wilkinson et al., 
2016), but the feasibility of such an approach in the context of aphasia rehabilitation 
research had not yet been examined; we set out to explore this.
Previous work has highlighted that health research protocols, full study reports, and 
participant-level datasets are not widely available in the public domain (Chan et al., 2014). 
However, recent initiatives that require the lodging of datasets in publicly available 
resources have changed the landscape of health research (Taichman et al., 2016). 
Additionally, in one study publications reporting study findings were available for only 
half of all studies (Chan et al., 2014), and can be subject to selective reporting or other 
sources of bias. A strength in our method of identifying eligible studies was that it relied 
not only on searches of the existing literature, but also on communication with existing 
international research networks such as the Collaboration of Aphasia Trialists (www. 
aphasiatrials.org) to identify potentially eligible datasets for inclusion. Our model builds 
on historical examples of in-house research activities that have included data sharing 
amongst specific research teams. Use of datasets based on availability and access within 
research groups can often bias dataset selection, impacting upon the representativeness 
of the data and limiting the generalisability of results.
Our study highlighted some restrictions to collaborative approaches. Despite our wide 
eligibility criteria and our systematic identification of, and open invitation to principal 
investigators with potentially eligible datasets, we were only able to acquire a subset of 
potentially eligible datasets; of 698 datasets identified as potentially eligible, 267 were 
unavailable for data sharing.
We highlighted several important methodological steps that were required to develop 
this international database. These included the establishment of relevant but inclusive 
eligibility criteria, the systematic identification of eligible studies using multiple informa-
tion sources, open invitation to international researchers to contribute data, collaborative 
working and consensus building to agree on variable parameters and categories, cleaning 
and standardisation of the data, and finally transparent description of the database to 
facilitate informed exploratory analyses. This model can be used by investigators in other 
health research areas to create similar data repositories within which to conduct explora-
tory analyses. Beyond the RELEASE project, a long-term legacy, big data repository for 
aphasia datasets is under development within the Collaboration of Aphasia Trialists, using 
the principles set out above. We invite further contributions of eligible datasets to this 
aphasia archive, to facilitate future analyses for the benefit of people with aphasia.
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